75 related articles for article (PubMed ID: 886527)
1. [The results of radiotherapy managements in Hodgkin's disease (author's transl)].
Duchamp C; Clément R; Juin P
J Radiol Electrol Med Nucl; 1977 May; 58(5):335-42. PubMed ID: 886527
[TBL] [Abstract][Full Text] [Related]
2. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
[No Abstract] [Full Text] [Related]
5. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
[TBL] [Abstract][Full Text] [Related]
6. [Polychemotherapy of Hodgkin's disease (author's transl)].
Jacquillat CL; Weil M; Auclerc G; Delbrück H; Chastang CL; Chelloul N; Boiron M; Bernard J
Dtsch Med Wochenschr; 1975 Apr; 100(15):785-90. PubMed ID: 1122828
[TBL] [Abstract][Full Text] [Related]
7. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
[No Abstract] [Full Text] [Related]
10. [Hodgkin's disease in children: long-term therapeutic results (author's transl)].
Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
Bull Cancer; 1981; 68(5):456-64. PubMed ID: 6800427
[TBL] [Abstract][Full Text] [Related]
11. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
[TBL] [Abstract][Full Text] [Related]
13. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
14. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
15. [The role of radiotherapy in the treatment of Hodgkin's disease].
Saito Y; Hirose J; Chohtoh S; Nishijima H; Kobayashi A; Kamimura R; Takashima T; Ohtake S; Yoshida T; Nakamura S
Gan No Rinsho; 1985 Dec; 31(15):1899-904. PubMed ID: 3841562
[TBL] [Abstract][Full Text] [Related]
16. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
17. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
[TBL] [Abstract][Full Text] [Related]
18. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
19. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
